Contribution of decreased expression of Ku70 to enhanced radiosensitivity by sodium butyrate in glioblastoma cell line (U251)

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 3, 2011, Pages 359-364

  Li, Yuhui ^a,b   Zhou, Hongxia ^a   Xing, Enming ^a   Dassarath, Meera ^a,c   Ren, Jinghua ^a   Dong, Xiaorong ^a   Liu, Hongli ^a   Yang, Kunyu ^a   Wu, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN CENTRAL HOSPITAL   (China)

^c Queen Victoria Hospital   (Mauritius)

Author keywords

H2AX; DNA double strand breaks; Ku70; Radiosensitivity; Sodium butyrate

Indexed keywords

BUTYRIC ACID DERIVATIVE; CELL NUCLEUS ANTIGEN; DNA BINDING PROTEIN; H2AFX PROTEIN, HUMAN; HISTONE; KU ANTIGEN; MESSENGER RNA;

ARTICLE; BRAIN TUMOR; GENETICS; GLIOBLASTOMA; HUMAN; METABOLISM; PATHOLOGY; RADIATION DOSE; TUMOR CELL LINE;

ANTIGENS, NUCLEAR; BRAIN NEOPLASMS; BUTYRATES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GLIOBLASTOMA; HISTONES; HUMANS; RADIATION TOLERANCE; RNA, MESSENGER;

EID: 80455123679     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0381-8     Document Type: Article

References (42)

1. Van Meir EG, Hadjipanayis CG, Norden AD, et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin, 2010,60(3): 166-193
2. Munshi A, Tanaka T, Hobbs ML, et al. Vorinostat, a his-tone deacetylase inhibitor, enhances the response of hu-man tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Mol Cancer Ther, 2006,5(8):1967-1974 (Pubitemid 44336568)
3. Geng L, Cuneo KC, Fu A, et al. Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cyto-plasm in irradiated non-small cell lung cancer. Cancer Res, 2006,66(23):11298-11304 (Pubitemid 46009960)
4. Kwon HK, Ahn SH, Park SH, et al. A novel gamma-lactam-based histone deacetylase inhibitor potently inhibits the growth of human breast and renal cancer cells. Biol Pharm Bull, 2009,32(10):1723-1727
5. Entin-Meer M, Yang X, VandenBerg SR, et al. In vivo efficacy of a novel histone deacetylase inhibitor in com-bination with radiation for the treatment of gliomas. Neuro Oncol, 2007,9(2):82-88 (Pubitemid 46580309)
6. Abbas A, Gupta S. The role of histone deacetylases in prostate cancer. Epigenetics, 2008,3(6):300-309
7. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature, 1997,389(6649):349-352 (Pubitemid 27415209)
8. Struhl K. Histone acetylation and transcriptional regula-tory mechanisms. Genes Dev, 1998,12(5):599-606 (Pubitemid 28134293)
9. Kim YB, Ki SW, Yoshida M, et al. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. J Antibiot (Tokyo), 2000,53(10): 1191-1200
10. Mai A, Massa S, Rotili D, et al. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Med Res Rev, 2005,25(3):261-309 (Pubitemid 40489663)
11. Gibson PR. The intracellular target of butyrate's actions: HDAC or HDON'TII Gut, 2000,46(4):447-448 (Pubitemid 30305801)
12. Munshi A, Kurland JF, Nishikawa T, et al. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res, 2005,11(13):4912-4922 (Pubitemid 41557212)
13. Arundel CM, Glicksman AS, Leith JT. Enhancement of radiation injury in human colon tumor cells by the matu-rational agent sodium butyrate (NaB). Radiat Res, 1985,104(3):443-448 (Pubitemid 16146490)
14. Fernandez-Capetillo O, Chen HT, Celeste A, et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol, 2002,4(12):993-997 (Pubitemid 35469431)
15. Russo AL, Kwon HC, Burgan WE, et al. In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016. Clin Cancer Res, 2009,15(2):607-612
16. Joachimiak R, Kaznica A, Drewa T. Influence of sodium butyrate on hepatocellular carcinoma (hepG2) and glioblastoma (C6) cell lines in vitro. Acta Pol Pharm, 2007,64(6):561-563 (Pubitemid 351360389)
17. Louis M, Rosato RR, Brault L, et al. The histone deace-tylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. Int J Oncol, 2004,25(6):1701-1711
18. Wang L, Luo HS, Xia H. Sodium butyrate induces human colon carcinoma HT-29 cell apoptosis through a mito-chondrial pathway. J Int Med Res, 2009,37(3): 803-811
19. Litvak DA, Hwang KO, Evers BM, et al. Induction of apoptosis in human gastric cancer by sodium butyrate. Anticancer Res, 2000,20(2A):779-784 (Pubitemid 30240633)
20. Toyooka T, Ibuki Y. Histone deacetylase inhibitor sodium butyrate enhances the cell killing effect of psoralen plus UVA by attenuating nucleotide excision repair. Cancer Res, 2009,69(8):3492-3500
21. Wei ZL, Zhao QL, Yu DY, et al. Enhancement of sodium butyrate-induced cell death and apoptosis by X-irradiation in the human colorectal cancer cell line HCT 116. Oncol Rep, 2008,20(2):397-403
22. Adimoolam S, Sirisawad M, Chen J, et al. HDAC inhibi- tor PCI-24781 decreases RAD51 expression and inhibits homologous recombination. Proc Natl Acad Sci U S A, 2007,104(49):19482-19487
23. Zhang Y, Carr T, Dimtchev A, et al. Attenuated DNA damage repair by trichostatin A through BRCA1 suppression. Radiat Res, 2007,168(1):115-124 (Pubitemid 351292932)
24. Zhang F, Zhang T, Teng ZH, et al. Sensitization to gamma-irradiation- induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells. Cancer Biol Ther, 2009,8(9):823-831
25. Marks PA, Richon VM, Breslow R, et al. Histone deace-tylase inhibitors as new cancer drugs. Curr Opin Oncol, 2001,13(6):477-483 (Pubitemid 33027900)
26. Chen JS, Faller DV. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. J Cell Physiol, 2005,202(1):87-99 (Pubitemid 39603365)
27. Banuelos CA, Banath JP, MacPhail SH, et al. Radiosensi- tization by the histone deacetylase inhibitor PCI-24781. Clin Cancer Res, 2007,13(22Pt1):6816- 6826 (Pubitemid 350206820)
28. Frew AJ, Johnstone RW, Bolden JE. Enhancing the apop-totic and therapeutic effects of HDAC inhibitors. Cancer Lett, 2009,280(2):125-133
29. Olive PL. The role of DNA single- and double-strand breaks in cell killing by ionizing radiation. Radiat Res, 1998,150(5 Suppl):S42-51 (Pubitemid 28519050)
30. Komuro Y, Watanabe T, Hosoi Y, et al. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer, 2002,95(6):1199-1205 (Pubitemid 35013052)
31. Wilson CR, Davidson SE, Margison GP, et al. Expression of Ku70 correlates with survival in carcinoma of the cer-vix. Br J Cancer, 2000,83(12):1702-1706 (Pubitemid 32001717)
32. Zhao HJ, Hosoi Y, Miyachi H, et al. DNA-dependent protein kinase activity correlates with Ku70 expression and radiation sensitivity in esophageal cancer cell lines. Clin Cancer Res, 2000,6(3):1073-1078 (Pubitemid 30159369)
33. Vaganay-Juery S, Muller C, Marangoni E, et al. De-creased DNA-PK activity in human cancer cells exhibit- ing hypersensitivity to low-dose irradiation. Br J Cancer, 2000,83(4):514-518 (Pubitemid 30487866)
34. Omori S, Takiguchi Y, Suda A, et al. Suppression of a DNA double-strand break repair gene, Ku70, increases radio- and chemosensitivity in a human lung carcinoma cell line. DNA Repair (Amst), 2002,1(4):299-310 (Pubitemid 38340226)
35. Podhorecka M. Gamma H2AX in the recognition of DNA double-strand breaks. Postepy Hig Med Dosw (Online), 2009,63:92-98
36. Sedelnikova OA, Rogakou EP, Panyutin IG, et al. Quan-titative detection of (125)IdU-induced DNA dou-ble-strand breaks with gamma-H2AX antibody. Radiat Res, 2002,158(4):486-492
37. Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci USA, 2003,100(9): 5057-5062 (Pubitemid 36542657)
38. Banath JP, Macphail SH, Olive PL. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res, 2004,64(19):7144-7149 (Pubitemid 39331029)
39. MacPhail SH, Banath JP, Yu TY, et al. Expression of phosphorylated histone H2AX in cultured cell lines fol-lowing exposure to X-rays. Int J Radiat Biol, 2003,79(5):351-358 (Pubitemid 36920536)
40. Svetlova MP, Solovjeva LV, Tomilin NV. Mechanism of elimination of phosphorylated histone H2AX from chro-matin after repair of DNA double-strand breaks. Mutat Res, 2010,685(1-2):54-60
41. Kuribayashi T, Ohara M, Sora S, et al. Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation. Int J Mol Med, 2010,25(1):25-29
42. Kim IA, Kim IH, Kim HJ, et al. HDAC inhibi- tor-mediated radiosensitization in human carcinoma cells: a general phenomenonII J Radiat Res (Tokyo), 2010,51(3):257-263